HFT CENTRAL OFFICE FROM SATALITE

VIDEOs ON HEPATITIS & ABOUT ORG

Saturday, March 26, 2011

Hepatitis Foundation Of Tripura with South AFRICA, US AMERICA, Switzerland, Bangkok, HONG KONG, Taiwan, Bangladesh, Chine experts organising INTERNATIONAL HFT-LIVER CONFERENCE 2011


South AFRICA, US AMERICA, Switzerland, Bangkok, HONG KONG, Taiwan, Bangladesh, Chine reaching AGMC to Study MAKING of Tripura 19.25% HEPATITIS B FREE & to FELICITATE Hepatitis Foundation Of Tripura in INTERNATIONAL HFT-LIVER CONFERENCE 2011.



HFT LIVER-CON 2011

   Hepatitis Foundation of Tripura has became a role model of study in Hepatitis b immunisation management towards the world nation. The experts & Herpetologists from Taiwan, Chine, Bangladesh and else from abroad and domestic Hepatitis B management organisation and Hepatitis Research Institutes will be reached on 23 April 2011 at Agartala to know about the Hepatitis Foundation of tripura Management and its movement culture that confirmed Tripura State 19.25% Hepatitis B free.

The occasion will be celebrated as the International HFT-Liver Conference 2011 at Agartala specifically at Agaratala Govt Medical College where the world nation will be feliciate the HFT and make a joint study of the Status of the Hepatitis b Prevalence in Tripura apart from HFT immunisation management. The International HFT-Liver Conference will be held on 23-24 April 2011 under the supervision of HEPATITIS FOUNDATION OF TRIPURA.

Dr Pradip Bhaumik revealed the agenda to the Press and said, the experts from South AFRICA, US AMERICA, Chine, Switzerland, Bangkok, HONG KONG, Taiwan, and also from Bangladesh will reach at Agartala to make their study about the activity and achievement of Hepatitis Foundation Of Tripura apart from to find various medical aspects regrading Hepatitis B management. In the domestic senerio Hepatitis Foundation Of Tripura will invite Dr S K SHARINE from NEW DELHI, Dr GORGE CHANDI from CMC VELORE, Dr Y K CHAWLA from CHANDIGAR, Dr S P SING from CUTTAK-ORISSA, Dr ABHIJIT CHAWDHURY & Dr SUJIT PURAKAYESTHA from KOLKATTA, Dr B D GOSWAMI from GUWAHATI. Dr MAMOON AL MEHTAB (Asst Prof Hepatology of Bangabandhu Sheikh Mujib Medical University apart Secretary General of Viral hepatitis Foundation and Association for the study of the Liver, Dhaka, Bangladesh and National Hepatology association of Bangladesh) will also attend the Conference with his team of experts to focus the Cross Border Hepatitis Transmission in between Tripura and Bangladesh.




Dr Pradip Bhaumik said, The Hepatitis Foundation of Tripura has already been succeeded to immunised the 19.25% of the state Tripura population by the eight activity years since 2002, when the organisation has been established with the motto to generate awareness among the backward state population and also to immunise them against Hepatitis B to ensure the Hepatitis B freedom in Tripura. He assured that the HFT will get to achieve to touch the level of 20% by APRIL 2011 before the Liver conference.

He said, The HFT's achievement credits belongs to the activities of the Organisation. To mark at that level of achievement the Hepatitis Foundation Of Tripura which has already been designated as a role model for HEPATITIS B FREEDOM MOVEMENT towards the whole world, is performing a encouraged way of the HFT Programmes which has also been framed in "multi centric" dimension due to its coverage policy from neonates through AT BIRTH HEPATITIS B VACCINATION to adults through Branch wise clinic networks through out the Tripura State Geo-area.

Dr Bhaumik Highlight, The Foundation performing its multi centric activities considering the transmission of the virus from Neonates to Adults including Pregnant and conducted HEPATITIS ERADICATION PROGRAMME subsequently for the two years in 2009-10 & in 2010-11, which is the ever first initiative of the organisation in INDIA among the globe apart from introducing the AT BIRTH HEPATITIS B VACCINATION PROGRAMME at the each GOVT hospitals to ensure the 100% Hepatitis B FREE gen-next, which is also be the ever first programme in INDIA along with its background field works.

Dr Bhaumik said, HFT is active in such field since 2002 and achieved to vaccinate the state population in a scientific manner. HFT achieved to vaccinate upto 2005 - 58181, in 2006 - 47708, in 2007 - 53804, in 2008 - 101800, in 2009 - 205500, in 2010 - 220347, hence for net totally 693265, out of which adult 384542 and children 308723. The achievement of HFT is significant as the total vaccinated population is the 19.25% of the state Tripura population.

Dr Bhaumik obliged to the TRIPURA STATE LEFT FRONT GOVERNMENT and said, The operation TO BE HEPATITIS B FREE has been come to the scenario as a marked and valued one due to the logistic, strenghtfull support of the Tripura state Left front Government as the total success story has its own Praised feature of "PPP" model in between both GOVT and NGO joint venture, which the rear most & unique of its kind in the national and international scenario.

Dr Pradip Bhaumik Said, To make a grand successful Liver conference at that level HFT prepared a management team of 57 members from both HFT, Agartala Govt Medical College (AGMC) and the Tripura administration headed by the Chairperson Dr Beenapani Doley, Prof & HOD - Medicine Dept, AGMC and Oraganising Secretary Dr Ajit Ranjan Chawdhury, Sr Gastro-entrerologist, AGMC with Press Secretary ANJAN BANIK.

Baruch Blumberg, Who Discovered and Tackled Hepatitis B, Dies at 85

Dr. Baruch S. Blumberg, the Nobel Prize-winning biochemist and medical anthropologist who discovered the hepatitis B virus, showed that it could cause liver cancer and then helped develop a powerful vaccine to fight it, saving millions of lives, died Tuesday in Moffett Field, Calif. He was 85 and lived in Philadelphia.



His family said he died, apparently of a heart attack, shortly after giving a keynote speech at a NASA conference at the Ames Research Center in Moffett Field, which is in the San Francisco Bay area. Dr. Blumberg had long been associated with a NASA project to hunt for micro-organisms in space.


Dr. Blumberg’s prize-winning virology and epidemiology work began in the 1960s at the Fox Chase Cancer Center in Philadelphia and took him and his colleagues on field trips around the world, from Japan to Africa.


The work led to the discovery of the hepatitis B virus in 1967, the first test for hepatitis B in the blood supply and the development in 1969 of the hepatitis B vaccine — the first “cancer vaccine.” Dr. Irving Millman, a colleague at the research center, was its co-creator.


Dr. Blumberg’s discoveries have been compared to those of Jonas Salk, the developer of the polio vaccine. He shared the Nobel Prize in Physiology or Medicine in 1976 with D. Carleton Gajdusek for their work on the origins and spread of infectious viral diseases. (Dr. Gajdusek had discovered the cause of the kuru, or “trembling disease,” prevalent in New Guinea.)


Almost 20 years later, after decades of hepatitis B-related studies and a global search for medicinal plants to treat hepatic infections, Dr. Blumberg began what he called his second career. In 1999 he became the founding director of the National Aeronautics and Space Administration’s Astrobiology Institute.


The institute’s mission was to oversee research teams in the development of life-detecting devices for planetary rovers and asteroid fly-bys, and to scrutinize life forms in “extreme” environments on Earth, like the ocean bottom and the geothermal cauldrons that produce geysers. He joined several expeditions himself.


To these seemingly disparate endeavors — investigating disease-causing organisms and postulating alien or primordial life forms — Dr. Blumberg contributed a broadened understanding of the evolutionary phenomenon called polymorphism, in which a species can adapt to an environment through changes in appearances and functions.


From his base in Philadelphia, Dr. Blumberg began investigating viruses with a study of yellow jaundice, so named because of the characteristic vivid yellowing of the eyes and skin. As early as 1940, medical researchers had determined that there were two different forms of virus-induced jaundice, one that is transmitted as an intestinal infection, and the other spread mainly by blood transfusions.


Scientific field trips to pinpoint the agent responsible for blood-borne jaundice were conducted by Dr. Blumberg and his colleagues in the Philippines, India, Japan, Canada, Scandinavia, Australia and Africa. Ultimately it was blood serum from an infected Australian aborigine that yielded the so-called Australian antigen, a protein found on the surface of the hepatitis B virus.


After he and Dr. Millman developed the hepatitis vaccine, they struggled to interest a pharmaceutical company to help develop and produce it.


“Vaccines are not an attractive product for pharmaceutical companies in that they are often used once or only a few times and they ordinarily do not generate as much income as a medication for a chronic disease that must be used for many years,” Dr. Blumberg wrote in an autobiographical essay for the Nobel committee.


Moreover, he said, the medical research community in the early 1970s remained skeptical about the claim that a virus had been identified and a vaccine developed.


Ultimately he and Dr. Millman signed an agreement with Merck & Company, whose vaccine laboratories were near Philadelphia.


Dr. Blumberg’s discoveries are credited with saving millions of patients from ever developing liver cancer. But in his scientific autobiography, “Hepatitis B: The Hunt for a Killer Virus” (Princeton University Press, 2002), he observed ruefully that hepatic disease was still killing 1.5 million people a year worldwide — despite the widespread availability of the vaccines he helped develop — and that 350 million were chronically infected.


Still, he was hopeful. “Life — and death — are full of surprises,” he wrote, “and while it may be tempting fate to be too optimistic, it appears likely that within the next few decades this virus will be effectively controlled.” (There is still no vaccine for the blood-borne hepatitis C, one of the five known hepatitis viruses.)


Dr. Blumberg’s traced his fascination with inherited variations in susceptibility to disease to the volunteer service he did during medical school at an isolated mining town in northern Surinam, where he delivered babies, performed clinical services and undertook the first malaria survey done in that region.


He was particularly interested in the sugar plantation workers who had been imported from several continents.


“Hindus from India, Javanese, Africans (including the Djukas, descendants of rebelled slaves who resided in autonomous kingdoms in the interior), Chinese, and a smattering of Jews descended from 17th century migrants to the country from Brazil, lived side by side,” Dr. Blumberg wrote in his Nobel essay. “Their responses to the many infectious agents in the environment were very different.”


He wrote his first scientific paper based on these studies and would revisit the tropics repeatedly. “Nature operates in bold and dramatic manner in the tropics,” he wrote.


By the late 1990s Dr. Blumberg was immersed in astrobiology, as NASA called the new science. Appointed by the NASA administrator, Dan Goldin, to lead the Astrobiology Institute, Dr. Blumberg and his team were asked to address three profound questions: How does life begin and evolve? Does life exist elsewhere in the universe? And what is life’s future on Earth and beyond?


As in his disease studies, Dr. Blumberg sought collaborations with specialists in a variety of fields, including physics, chemistry, geology, paleontology and oceanography as well as biology and medicine that would “help us to recognize biospheres that might be different from our own.”




While urging the development of instrumentation for astrobiological space probes, Dr. Blumberg recommended equal efforts in the study of earthly “extremophiles,” the organisms that somehow thrive in extreme temperatures, pressures and chemical conditions.


In fissures in the deep ocean floor, Dr. Blumberg said, are extremophiles that might resemble the earliest life forms on Earth or other planets. He described Earth as “a place of extremes” during the first few hundred million years of its 4.5-billion-year existence, given to radical climate fluctuations, from searing heat to immobilizing cold, amid constant meteorite bombardments and catastrophic volcanic eruptions.


He speculated that life might have started on Earth at geothermal sites, either underground or in the sea. The NASA venture — since diminished by administrative changes and financing cutbacks — was welcomed by those who advocate a search for extraterrestrial intelligence, known as SETI, and call the science “exobiology.” Dr. Blumberg joined the board of the SETI Institute in Mountain View, Calif.


But in an interview with The New York Times in 2002, he said he would be “very surprised if we found something in space, that it would look like E.T.”


“If we found something more like a virus or a bacteria,” he said, “that would be astounding enough.”


Baruch Samuel Blumberg (Barry to his friends) was born in New York City on July 28, 1925, the second of three children of Meyer Blumberg, a lawyer, and Ida Blumberg. After attending the Yeshiva of Flatbush in Brooklyn, he went to Far Rockaway High School in Queens (whose graduates also include the Nobel physicists Richard Feynman and Burton Richter).


His undergraduate studies at Union College in Schenectady, N.Y., were interrupted by World War II, when he served as a Navy deck officer on landing ships. Returning to Union College, he completed a bachelor’s degree in physics, enrolled in graduate studies of mathematics at Columbia and transferred to Columbia’s College of Physicians and Surgeons, earning his M.D. there in 1951.


Dr. Blumberg served a clinical fellowship at Columbia Presbyterian Medical Center, went to Oxford University’s Balliol College for a doctorate in biochemistry, and returned to the United States in 1957 to join the National Institutes of Health, where he headed the Geographic Medicine and Genetics Section until 1964.


Most of his research afterward was conducted at the Fox Chase Cancer Center. Dr. Blumberg was also on the faculty of the University of Pennsylvania and its School of Medicine as a professor of medicine, medical genetics and medical anthropology.


Dr. Blumberg married Jean Liebesman, an artist, in 1954. She survives him, as do two daughters, Anne Blumberg of Boston and Jane Blumberg of Oxford, England; two sons, George, of Oxford, and Noah, of Chevy Chase, Md.; and nine grandchildren.


Dr. Blumberg saw his Nobel as more than an act of recognition. He said it helped draw renewed attention to his work with enormously beneficial consequences. After receiving the prize, he said, he was invited to China. “I spoke before several thousand people,” he told The Times in 2002. “I provided them with a copy of the patent, and now I’m told that it helped to change the direction of what they were doing and led to the saving of a lot of lives.”


Saving lives, he said, was the whole point of his career. “Well, it is something I always wanted to do,” he said. “This is what drew me to medicine. There is, in Jewish thought, this idea that if you save a single life, you save the whole world, and that affected me.”


SOURCE :

http://www.nytimes.com/2011/04/07/health/07blumberg.html?pagewanted=1&_r=1

Monday, March 21, 2011

Make GENEXT cent PERCENT HEPATITIS B FREE: Hepatitis Foundation Of Tripura initiative of AT BIRTH IMMUNISATION recognised at TRIPURA LEGISLATIVE ASSEMBLY

Make GENEXT cent PERCENT HEPATITIS B FREE: Hepatitis Foundation Of Tripura initiative of AT BIRTH IMMUNISATION recognised at TRIPURA LEGISLATIVE ASSEMBLY

Hepatitis Foundation of Tripura has been recognised in Tripura Legislative Assembly organised in the recent last days. The Director of Family welfare of Govt of Tripura Dr R k Dhar informed about the happenings in his official letter to HEPATITIS FOUNDATION OF Tripura vide No F-1 (118) AQ/GS/2011 dated agartala 10th March 2011.

In his letter to the President of Hepatitis Foundation of Tripura he revealed that the Leader of Opposition Mr R. L. Nath has been lodged a query about the on going Prestigious programme of HFT on At Birth Hepatitis B Vaccination, which has already been recognised world wide as a ever first initiative in any state level and only through the active support of any N.G.O in India. The asked question has been segmented under the Assembly admitted un-starred Question No 370 in the session of recently closed TLA Budget Session.






























Answering the Question to the Director of Dept of Preventive Medicine and Family Welfare of Govt of Tripura, Dr Pradip Bhaumik, Being the President of Hepatitis Foundation of Tripura Revealed that in two Month after starting the Programme HFT achieved to immunise 935 Neo-natents under the 17 state govt hospitals, which is in 95% covered hospital regarded as 100% new born coverage towards At Birth Hepatitis B Immunisation.

Dr Pradip Bhaumik revealed the facts to the Press and said, The India's ever First At Birth Hepatitis B Immunisation Programme at the Govt Hospital Level Has been inaugurated at Indira Gandhi Memorial Hospital (Known as also Victoria Memorial Hospital) Agartala on 7th January 2011. Aftermath of the inauguratory event the Organisation has been expanded its programme at various district and sub divisional Hospitals of the State Tripura under the organisational strategy - Hepatitis Foundation of Tripura - Hepatitis Education and Life Protection (HELP) PLUS Programme.

Dr Pradip Bhaumik said, In January 2011 aftermath of inauguration Hepatitis Foundation of Tripura succeed to extend its facilities of At birth Vaccination in 2 (two) Hospitals of South Tripura District apart from the debut Hospital Indira Gandhi Memorial Hospital (Known as also Victoria Memorial Hospital) Agartala, which has been recognise finally 3 (three) Hospital out of 2 (two) Districts of the state Tripura.

He Informed the Department that in Januray 2011, HELP PLUS programme achieved to immunise 327 new born babies in Indira Gandhi Memorial Hospital (Known as also Victoria Memorial Hospital) Agartala of west Tripura whereas in South Tripura Dist achieved to immunise only 6 new born babeis at its 2 (two) covered Hospitals.

He Said, The Govt official and service holders of the concern Hospitals are not yet too much educated to operate the programme, which is the main reason of back pulling of the programme in the remote District.

Elaborateing the facts of February 2011 in connection to the question set by the leader of opposition of Tripura Legislative Assembly Ratan Lal Nath, Dr Pradip Bhaumik Said, In February the HELP PLUS programme has been expanded to the other parts of the state and finally confirmed the coverage of the AT BIRTH Hepatitis B Vaccination Programme at 17 Govt Hospitals of the states by 28th Feb 2011. Out of all 17 Govt Hospitals the west Tripura District has been covered with 5 (five) hospitals, South Tripura District has been covered with 6 (SIX) hospitals, North Tripura District has been covered with 3 (three) hospitals & Dhalai Tripura District has been covered with 3 (Three) hospitals.

He Highlight, Hepatitis Foundation of Tripura with its HELP PLUS programme in Feb 2011 wrote a history through immunising total 602 neonates in the second & single month, where the west Tripura district reported to immunise 398 new borns, South Tripura district reported to immunise 122 new borns, North Tripura district reported to immunise 56 new borns & Dhalai Tripura district reported to immunise 26 new borns.

He said Finally in two Debut months onwards 7th January 2011 and aftermath of inauguration of the HELP PLUS Hepatitis Foundation of Tripura programme the Hepatitis Foundation of Tripura succed to cover all 17 Govt Hospital and totally - finally 935 new born babies. In this Two Month, Out of the total 935 new born babis covered against the whole Tripura state senerio the west Tripura dist, South Tripura, North Tripura & Dhalai District Respectively covered 725 new born babis apart 128 new born babis, 56 new born babis and 26 new born babis.

Addressing the well wishers of Hepatitis Foundation of Tripura, President Dr Pradip Bhaumik said, Hepatitis Foundation of Tripura by now have coverage of total 23 Govt Hospitals in the Tripura state. according to the Inauguration of the At Birth Hepatitis B immunisation Programme Hepatitis Foundation of Tripura started its oparetion at Indira Gandhi Memorial Hospital (Known as also Victoria Memorial Hospital) Agartala of west Tripura on 7th January 2011 and thereafter Belonia on 30 january 2011, Santirbazar on 31 January 2011, Sabroom on 1st Feb 2011, Sonamura on 2 Feb 2011, Bamutia on 6 Feb 2011, Muhuripur on 11 Feb 2011, KumarGhat on 12 Feb 2011, Dharmanagar on 13th Feb 2011, Kamalpur on 15 Feb, Khowai on 21 Feb 2011, Kailashahar on 23 Feb, Amarpur on 24 Feb, Melagar, ManuGhat & Kulai both on 27 Feb, Udaipur on 28 Feb apart Manu bazar on 1 March, Ganda Chara on 3 March, Kanchan pur and Bishramganj both on 4th march 2011.

Thanking the all Elected Members of Tripura Legislative Assembly He Said, HFT lunched its same concern programme at the AGARTALA GOVT MEDICAL COLLEGE AND GOVINDA BALLAV PANT HOSPITAL on 10th March 2011, which is the ever First At BIRTH HEPATITIS B IMMUNISATION PROGRAMME that has been implemented at any Medical College any where in India too.

He said, The HFT's achievement credits belongs to the activities of the Organisation. To mark at that level of achievement the Hepatitis Foundation Of Tripura which has already been designated as a role model for HEPATITIS B FREEDOM MOVEMENT towards the whole world, is performing a encouraged way of the HFT Programmes which has also been framed in "multi centric" dimension due to its coverage policy from neonates through AT BIRTH HEPATITIS B VACCINATION to adults through Branch wise clinic networks through out the Tripura State Geo-area.

Dr Bhaumik Highlight, The Foundation performing its multi centric activities considering the transmission of the virus from Neonates to Adults including Pregnant and conducted HEPATITIS ERADICATION PROGRAMME subsequently for the two years in 2009-10 & in 2010-11, which is the ever first initiative of the organisation in INDIA among the globe apart from introducing the AT BIRTH HEPATITIS B VACCINATION PROGRAMME at the each GOVT hospitals to ensure the 100% Hepatitis B FREE gen-next, which is also be the ever first programme in INDIA along with its background field works.

Dr Bhaumik obliged to the TRIPURA STATE LEFT FRONT GOVERNMENT and said, The operation TO BE HEPATITIS B FREE has been come to the scenario as a marked and valued one due to the logistic, strenghtfull support of the Tripura state Left front Government as the total success story has its own Praised feature of "PPP" model in between both GOVT and NGO joint venture, which the rear most & unique of its kind in the national and international scenario.